25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr

Details 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr

1987-09-21

1989-11-28

Konopka, Paul E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

514891, A61K 3159

Patent

active

048837911

ABSTRACT:
The invention is directed to a method in the treatment of hypercalcitriolemic disease states which comprises administering an effective amount of 25S,26-dihydroxycholecalciferol to a host in need of such treatment.

REFERENCES:
patent: 4617297 (1986-10-01), Boris
Endocrinology, vol. 121, No. 5, (1987) pp. 1671-1677, Joseph E. Zerwekh et al.
Steroids, vol. 32, No. 5 (Dec. 1978) pp. 577-587, Monique Thomasset et al.
Chemical Abstracts-vol. 90, 1979-115285X.
Chemical Abstracts-vol. 107, 1987-235294r.
Breslau et al., "Effects of Short Term Glucocoticoid Administration in Primary Hyperparathyroidism: Comparison to Sarcoidosis", J. Clin. Endocrinol, Metab. 58:824 (1982).

Affiliated with

Also associated with

Rating

25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-581895